Literature DB >> 15787241

The antimicrobial activity of extracts of the lichen Hypogymnia tubulosa and its 3-hydroxyphysodic acid constituent.

Meral Yilmaz1, Turgay Tay, Merih Kivanç, Hayrettin Türk, Ayşen Ozdemir Türk.   

Abstract

The antimicrobial activity and the MIC values of the diethyl ether, acetone, chloroform, petroleum ether, and ethanol extracts of the lichen Hypogymnia tubulosa and its 3-hydroxyphysodic acid constituent have been investigated against some microorganisms. At least one of the extracts or 3-hydroxyphysodic acid showed antimicrobial activity against Aeromonas hydrophila, Bacillus cereus, Bacillus subtilis, Escherichia coli, Klebsiella pneumoniae, Listeria monocytogenes, Proteus vulgaris, Salmonella typhimurium, Staphylococcus aureus, Streptococcus faecalis, and Candida albicans. No antifungal activity of the extracts has been observed against ten filamentous fungi.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15787241     DOI: 10.1515/znc-2005-1-207

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  4 in total

1.  In Vitro Antimicrobial Potential of the Lichen Parmotrema sp. Extracts against Various Pathogens.

Authors:  Ritika Chauhan; Jayanthi Abraham
Journal:  Iran J Basic Med Sci       Date:  2013-07       Impact factor: 2.699

2.  Agrobacterium tumefaciens-mediated transformation of the lichen fungus, Umbilicaria muehlenbergii.

Authors:  Sook-Young Park; Min-Hye Jeong; Hai-Ying Wang; Jung A Kim; Nan-Hee Yu; Sungbeom Kim; Yong Hwa Cheong; Seogchan Kang; Yong-Hwan Lee; Jae-Seoun Hur
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

3.  Evaluation of Antimicrobial Properties of Lichen Substances against Plant Pathogens.

Authors:  Jaycee A Paguirigan; Rundong Liu; Seong Mi Im; Jae-Seoun Hur; Wonyong Kim
Journal:  Plant Pathol J       Date:  2022-02-01       Impact factor: 1.795

4.  Chemical Composition and Antimicrobial Activity of Two Sri Lankan Lichens, Parmotrema rampoddense, and Parmotrema tinctorum against Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus.

Authors:  Polwatta Samaraweera Arachchige Ishara Shiromi; Ruwani Punyakanthi Hewawasam; Rankoth Gedara Udeni Jayalal; Hasanga Rathnayake; Weerasinghe Mudiyanselage Dilip Gaya Bandara Wijayaratne; Dakshika Wanniarachchi
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-01       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.